News

Currently, The Female Health Company (FHC) is manufacturing its second-generation product, FC2, on four production lines in Malaysia. The company, in conjunction with its Indian partner, HLL Lifecare,

The double-blind, vehicle-controlled study is designed to evaluate the tolerability, pharmacokinetics, and efficacy of the topical product in a total of 18 subjects with mild to moderate plaque

Dara Biosciences, a development-stage pharmaceutical company, has announced that the FDA has cleared the company’s investigational new drug application for DB959, allowing Dara to commence Phase I studies

Cell Genesys, a biotechnology company, has reported a net loss of $13.3m, or $0.15 per diluted share, for the fourth quarter of 2008, compared to a net loss

EnteroMedics, a medical device company, has received the CE Mark approval for its Vbloc therapy delivered via the Maestro system for the treatment of obesity. The Maestro system

The company reported revenues of $82.85 million for the year ended December 31, 2008, compared to $44.34 million for the year ended December 31, 2007. The increase in

Eurand, a specialty pharmaceutical company, has received the FDA orphan drug designation for EUR-1073 in pediatric patients. EUR-1073 is a proprietary development product for the treatment of ulcerative

For the 12 months ended December 31, 2008, the company reported a net loss of $8 million, or $0.43 per share, compared to a net loss of $24.6

According to the company, the HemAway Seat is a painless, non-invasive, discreet, and easy-to-use hemorrhoid treatment device that alleviates the discomfort and agony of prolapsed internal hemorrhoids within